Polypharmacy in general practice

Danish Medical Bulletin

Volumn 57, Issue 7, 2010, Pages

  Schæfer, Kirsten ^a   Mærkedahl, Henrik ^b   Birk, Hans Okkels ^c   Henriksen, Lars Onsberg ^a  

^a Quality and Development   (Denmark)

^b General practice ^*  (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTIRHEUMATIC AGENT; CITALOPRAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSAMINE DERIVATIVE; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR; QUININE; TODOLAC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DENMARK; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MAJOR POLYPHARMACY; MALE; MEDICAL AUDIT; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGISTER; TREATMENT INDICATION; CLINICAL PRACTICE; FACTUAL DATABASE; MIDDLE AGED; PREVALENCE; STATISTICS;

DATABASES, FACTUAL; DENMARK; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES;

EID: 77954582433     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hanlon JT, Schmader KE, Ruby CM et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001;49:200-9.
2. Bjerrum L, Gonzalez Lopez-Valcarcel B et al. Risk factors for potential drug interactions in general practice. Eur J Gen Pract 2008;14:23-9.
3. Sorensen L, Stokes JA, Purdie DM et al. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing 2005;34:626-32.
4. Schæfer K, Henriksen LO, Munck A et al. Ordination af lægemidler i almen praksis. En deskriptiv undersøgelse i solopraksis i det tidligere Roskilde Amt. Ugeskr Læger 2008;170:2327-30.
5. Gæde P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
6. Bjerrum L, Søgaard, Hallas J et al. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 1999;49:195-8.
7. Fialová D, Topinková E, Gambassi G. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293:1348-58.
8. Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 2006;4:134-43.
9. Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Man 2005;1:39-48.
10. www.statistikbanken.dk (14 July 2009).
11. http://www.irf.dk/dk/publikationer/rationel_farmakoterapi/maanedsblad/2002/nasid_-_oemme_punkter.htm (3 May 2010).
12. Veehof L, Stewart RE, Haaijer-Ruskamp FM et al. The development of polypharmacy. Fam Pract 2000;17:261-7.
13. Atkin AP, Veitch PC, Veitch EM et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999;14:141-52.
14. Bregnhøj L, Thirstrup S, Kristensen MB et al. Prevalence of inappropriate prescribing in primary care. Pharm World Sci 2007;29:109-15.
15. Rognstad S, Straand J. Vet fastlegen hvilke medisiner hjemmesykepleien gir pasientene? Tidsskr Nor Laegeforen 2004;124:810-2.
16. Barat I, Andreasen F, Damsgaard EMS. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharamcol 2000;56:501-9.
17. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of the literature. J Behav Med 2008;31:213-24.
18. Veehof L, Stewart RE, Meyboom-de Jong B et al. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999;55:533-6.
19. Foss S, Schmidt JR, Andersen T et al. Congruence on medication between patients and physicians involved in patient course. Eur J Clin Pharmacol 2004;59:841-7.
20. McGavock H, Wilson-Davis K, Connolly JP. Repeat prescribing management - a cause for concern? Br J Gen Pract 1999;49:343-7.